Horizon Discovery Group Plc (HZD):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Horizon Discovery Group Plc (HZD) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7837
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:37
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Horizon Discovery Group Plc (Horizon Discovery) is a life science company that discovers and develops genetically-modified cell lines using a proprietary translational genomics platform. The company offers products such as cell lines, reference standards and in vivo models. It also offers services such as CRISPR screening, combination screening, in vivo assay services and cell-based assays, among others. Horizon Discovery offers its products and services to genomic research organizations, pharmaceutical, biotechnology and diagnostic companies and academic research centers for the formulation of customized medicines. The company has operations in the UK and the US. Horizon Discovery is headquartered in Cambridge, the UK.

Horizon Discovery Group Plc (HZD) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Horizon Discovery Group Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Horizon Discovery Group Plc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Horizon Discovery Group Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Horizon Discovery Group Plc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Horizon Discovery Group Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Horizon Discovery Group Plc, Medical Equipment, Deal Details 11
Asset Purchase 11
Horizon Discovery Completes Acquisition of Combination High Throughput Screening from Zalicus 11
Private Equity 12
ValueAct Capital Acquires Additional Stake in Horizon Discovery Group from Woodford Investment Management 12
Partnerships 13
Horizon Discovery Enters into Licensing Agreement for Transposon Based Technology Platform 13
Horizon Discovery Enters into Licensing and Supply Agreement with Adarza BioSystems 14
Horizon Discovery Enters into Licensing Agreement with Japanese Medical University 15
Horizon Discovery Enters Into Licensing Agreement With ATCC 16
Horizon Diagnostics Enters Into Licensing Agreement With UK NEQAS 17
Horizon Discovery Enters into Partnership 18
Sophia Genetics Enters into Agreement with Horizon Discovery Group 19
Horizon Discovery Group Enters into Co-Development Agreement with Ventana Medical Systems 20
Agena Bioscience Enters into Agreement with Horizon Discovery 21
CareDx Enters into Co-Development Agreement with Horizon Discovery 22
Transgenomic Enters Into Co-Development Agreement With Horizon Diagnostics For Genetic Diagnostic Tests 23
Horizon Diagnostics Enters Into Distribution Agreement With Riken Genesis 24
Crown Bioscience Enters Into Agreement With Horizon Discovery To Develop In Vivo Models For Drug Discovery 25
Horizon Diagnostics Enters Into Distribution Agreement With Diatech Pharmacogenetics For Molecular Reference Standards 26
Crown Bioscience Enters Into Co-Development Agreement With Horizon Discovery 27
Horizon Discovery Enters into Licensing Agreement with US Immuno-Oncology Company 28
Equity Offering 29
Horizon Discovery Raises USD104.6 million in Private Placement of Shares 29
Horizon Discovery Group Plc – Key Competitors 30
Horizon Discovery Group Plc – Key Employees 31
Horizon Discovery Group Plc – Locations And Subsidiaries 32
Head Office 32
Other Locations & Subsidiaries 32
Joint Venture 33
Recent Developments 34
Product News 34
Sep 25, 2017: Horizon Discovery introduces OncoSpan, the world’s largest DNA multiplex Reference Standard for oncology 34
Feb 20, 2017: Horizon Discovery Launches Multiplex I cfDNA Reference Standard Set in Synthetic Plasma 35
Other Significant Developments 36
Mar 14, 2017: Horizon Discovery Enters into Agreement with a Leading Global Molecular Diagnostics Provider for Reference Standards for Non-Invasive Prenatal Testing 36
Appendix 37
Methodology 37
About GlobalData 37
Contact Us 37
Disclaimer 37

List of Tables
Horizon Discovery Group Plc, Medical Equipment, Key Facts, 2017 2
Horizon Discovery Group Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Horizon Discovery Group Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Horizon Discovery Group Plc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Horizon Discovery Group Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Horizon Discovery Group Plc, Deals By Market, 2012 to YTD 2018 8
Horizon Discovery Group Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Horizon Discovery Completes Acquisition of Combination High Throughput Screening from Zalicus 11
ValueAct Capital Acquires Additional Stake in Horizon Discovery Group from Woodford Investment Management 12
Horizon Discovery Enters into Licensing Agreement for Transposon Based Technology Platform 13
Horizon Discovery Enters into Licensing and Supply Agreement with Adarza BioSystems 14
Horizon Discovery Enters into Licensing Agreement with Japanese Medical University 15
Horizon Discovery Enters Into Licensing Agreement With ATCC 16
Horizon Diagnostics Enters Into Licensing Agreement With UK NEQAS 17
Horizon Discovery Enters into Partnership 18
Sophia Genetics Enters into Agreement with Horizon Discovery Group 19
Horizon Discovery Group Enters into Co-Development Agreement with Ventana Medical Systems 20
Agena Bioscience Enters into Agreement with Horizon Discovery 21
CareDx Enters into Co-Development Agreement with Horizon Discovery 22
Transgenomic Enters Into Co-Development Agreement With Horizon Diagnostics For Genetic Diagnostic Tests 23
Horizon Diagnostics Enters Into Distribution Agreement With Riken Genesis 24
Crown Bioscience Enters Into Agreement With Horizon Discovery To Develop In Vivo Models For Drug Discovery 25
Horizon Diagnostics Enters Into Distribution Agreement With Diatech Pharmacogenetics For Molecular Reference Standards 26
Crown Bioscience Enters Into Co-Development Agreement With Horizon Discovery 27
Horizon Discovery Enters into Licensing Agreement with US Immuno-Oncology Company 28
Horizon Discovery Raises USD104.6 million in Private Placement of Shares 29
Horizon Discovery Group Plc, Key Competitors 30
Horizon Discovery Group Plc, Key Employees 31
Horizon Discovery Group Plc, Other Locations 32
Horizon Discovery Group Plc, Subsidiaries 32
Horizon Discovery Group Plc, Joint Venture 33

List of Figures
Horizon Discovery Group Plc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Horizon Discovery Group Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Horizon Discovery Group Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Horizon Discovery Group Plc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Horizon Discovery Group Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Horizon Discovery Group Plc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Horizon Discovery Group Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Horizon Discovery Group Plc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Horizon Discovery Group Plc (HZD):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • B&G Foods, Inc.:企業の戦略・SWOT・財務情報
    B&G Foods, Inc. - Strategy, SWOT and Corporate Finance Report Summary B&G Foods, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Young’s Seafood Limited:企業の戦略・SWOT・財務情報
    Young's Seafood Limited - Strategy, SWOT and Corporate Finance Report Summary Young's Seafood Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Cincinnati Bell Inc.:企業の戦略・SWOT・財務情報
    Cincinnati Bell Inc. - Strategy, SWOT and Corporate Finance Report Summary Cincinnati Bell Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Probiogen AG-製薬・医療分野:企業M&A・提携分析
    Summary Probiogen AG (Probiogen), a subsidiary of Minapharm Pharmaceuticals & Chemical Industries is a contract development and manufacturing organization that offers cell line engineering, process development and GMP manufacturing of biopharmaceuticals. The organization’s services comprise therapeu …
  • General Dynamics Corp (GD):企業の財務・戦略的SWOT分析
    General Dynamics Corp (GD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Shields Bag And Printing Company
    Shields Bag And Printing Company - Strategy, SWOT and Corporate Finance Report Summary Shields Bag And Printing Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • GlobalData plc (PRO):企業の財務・戦略的SWOT分析
    Summary GlobalData Plc (GD), formerly Progressive Digital Media Group Plc, is a provider of data insights, analytics and information services. The company’s solutions encompass market and competitive analysis, strategic planning, mergers and acquisitions, financial decisions, legal and accounting, m …
  • PepsiCo Inc:企業のM&A・事業提携・投資動向
    PepsiCo Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's PepsiCo Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • Mapletree Investments Pte Ltd:企業の戦略的SWOT分析
    Mapletree Investments Pte Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • NIBC Bank NV:電力:M&Aディール及び事業提携情報
    Summary NIBC Bank NV (NIBC), a subsidiary of NIBC Holding NV, is an enterprising bank that provides a range of corporate and consumer banking services. The company specializes in mergers and acquisitions, debt and equity mezzanine, capitalization advisory, leveraged finance and structured finance, a …
  • New Jersey Resources Corp (NJR):企業の財務・戦略的SWOT分析
    New Jersey Resources Corp (NJR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Alleghany Corporation:企業の戦略・SWOT・財務情報
    Alleghany Corporation - Strategy, SWOT and Corporate Finance Report Summary Alleghany Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Ariste Medical LLC:医療機器:M&Aディール及び事業提携情報
    Summary Ariste Medical LLC (Ariste) is a medical device company that develops drug eluting surgical implants. The company develops drug eluting tunneled dialysis catheter for hemodialysis, drug eluting mesh for hernia repair, and drug eluting vascular graft for peripheral bypass. It also develops dr …
  • Tesaro Inc (TSRO)-製薬・医療分野:企業M&A・提携分析
    Summary Tesaro Inc (Tesaro) is an oncology-focused biopharmaceutical company that focuses on developing in-licensed, oncology-related product candidates, comprising rolapitant, niraparib, and the product candidates under its immuno-oncology platform. VARUBI, the company’s first commercial product is …
  • Ipsen S.A.:企業の戦略・SWOT・財務分析
    Ipsen S.A. - Strategy, SWOT and Corporate Finance Report Summary Ipsen S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Hitachi Metals, Ltd.:戦略・SWOT・企業財務分析
    Hitachi Metals, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Hitachi Metals, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Mr. Price Group Ltd.:戦略・SWOT・企業財務分析
    Mr. Price Group Ltd. - Strategy, SWOT and Corporate Finance Report Summary Mr. Price Group Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Santos Ltd (STO):石油・ガス:M&Aディール及び事業提携情報
    Summary Santos Ltd (Santos) is an independent oil and natural gas company. Its activities include onshore, offshore and liquefied natural gas (LNG) projects. The company has exploration and production acreage in Australia and Papua New Guinea. Its core natural gas assets include Cooper Basin, Queens …
  • Patria Oyj:企業の戦略・SWOT・財務情報
    Patria Oyj - Strategy, SWOT and Corporate Finance Report Summary Patria Oyj - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Ekarat Engineering (Public) Co Ltd (AKR):企業の財務・戦略的SWOT分析
    Ekarat Engineering (Public) Co Ltd (AKR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆